Newlimit

Brian Armstrong just raised $435 million for his longevity bet NewLimit, and that's the kind of number that makes you actually pause. The Coinbase CEO isn't just dabbling—he's building alongside genome engineer Blake Byers and Jacob Kimmel to attack human healthspan, not lifespan, which is the harder problem everyone else punts on. Half a billion buys you real runway, but proving you can extend the years people live well? That remains the most ambitious bet in biotech, period. Here's your signal.